BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37086063)

  • 1. Tri-modality therapy in advanced esophageal carcinoma: Long-term results and insights from a developing world, institutional cohort.
    Verma M; Singhal S; Ghosh A; Kukreja D
    Br J Radiol; 2023 Jun; 96(1146):20230150. PubMed ID: 37086063
    [No Abstract]   [Full Text] [Related]  

  • 2. Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort.
    Chufal KS; Ahmad I; Bajpai R; Miller AA; Chowdhary RL; Makker J; Batra U; Nathany S; Sharief MI; Umesh P; Sharma M; Amrith P; Pahuja AK; Sethi J; Antony V; Gairola M
    Br J Radiol; 2023 Mar; 96(1143):20220413. PubMed ID: 36541255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.
    Shaikh T; Zaki MA; Dominello MM; Handorf E; Konski AA; Cohen SJ; Shields A; Philip P; Meyer JE
    Acta Oncol; 2016; 55(3):303-8. PubMed ID: 26581671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategy for the treatment of esophageal carcinoma].
    Kuwano H; Sumiyoshi K; Nozoe T; Yasuda M; Watanabe M; Sugimachi K
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1577-82. PubMed ID: 8060131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy of esophageal cancer.
    Juergens RA; Forastiere A
    J Natl Compr Canc Netw; 2008 Oct; 6(9):851-60; quiz 861. PubMed ID: 18926094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality therapy in esophageal cancer.
    Neitlich HW
    J Clin Oncol; 1987 Nov; 5(11):1852. PubMed ID: 2445934
    [No Abstract]   [Full Text] [Related]  

  • 7. Esophageal carcinoma with tracheal stenosis due to tumor invasion and long survival after chemoradiotherapy.
    Kinoshita Y; Udagawa H; Tsutsumi K; Ueno M; Mine S; Hukuda S; Sasaki K; Matoba S; Hayakawa T; Matsuda M; Hashimoto M; Sawada T; Watanabe G
    Dis Esophagus; 2003; 16(3):261-4. PubMed ID: 14641322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An audit of combined modality therapy for esophageal squamous cell carcinoma from a teaching hospital in Iran.
    Toosi MS; Anvari K; Aledavood A; Nowferesti G; Mohtashami S
    Indian J Gastroenterol; 2008; 27(1):33-4. PubMed ID: 18541937
    [No Abstract]   [Full Text] [Related]  

  • 9. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
    Theisen J; Siewert JR
    MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma-Renewed Enthusiasm and a Lingering Challenge.
    DaSilva LL; Aguiar PN; de Lima Lopes G
    JAMA Oncol; 2021 Nov; 7(11):1613-1614. PubMed ID: 34519775
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidisciplinary modalities achieve encouraging long-term survival in resectable limited-disease esophageal small cell carcinoma.
    Hou X; Wei JC; Wu JX; Wang X; Fu JH; Lin P; Yang HX
    PLoS One; 2013; 8(7):e69259. PubMed ID: 23874925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survivors of esophageal carcinoma with distant lymph node metastasis.
    Okamura S; Fujiwara H; Shiozaki A; Komatsu S; Ichikawa D; Okamoto K; Murayama Y; Ikoma H; Kuriu Y; Nakanishi M; Ochiai T; Kokuba Y; Sonoyama T; Otsuji E
    Hepatogastroenterology; 2011; 58(106):421-5. PubMed ID: 21661407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality therapy in esophageal cancer.
    Einhorn LH
    J Clin Oncol; 1990 Jul; 8(7):1286-7. PubMed ID: 2358843
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.
    Shah MA; Kennedy EB; Catenacci DV; Deighton DC; Goodman KA; Malhotra NK; Willett C; Stiles B; Sharma P; Tang L; Wijnhoven BPL; Hofstetter WL
    J Clin Oncol; 2020 Aug; 38(23):2677-2694. PubMed ID: 32568633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients.
    Jung HK; Tae CH; Lee HA; Lee H; Don Choi K; Park JC; Kwon JG; Choi YJ; Hong SJ; Sung J; Chung WC; Kim KB; Kim SY; Song KH; Park KS; Jeon SW; Kim BW; Ryu HS; Lee OJ; Baik GH; Kim YS; Jung HY;
    PLoS One; 2020; 15(4):e0231456. PubMed ID: 32275699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multimodal therapy concepts in esophageal carcinoma].
    Porschen R; Roth SL; Röher HD; Strohmeyer G
    Dtsch Med Wochenschr; 1993 Apr; 118(17):634-40. PubMed ID: 8482241
    [No Abstract]   [Full Text] [Related]  

  • 17. Multimodal therapy for esophageal carcinoma.
    Lansing PB
    J La State Med Soc; 1985 Feb; 137(2):42-4. PubMed ID: 3981152
    [No Abstract]   [Full Text] [Related]  

  • 18. Esophageal carcinoma.
    Kreutzer EW
    Ear Nose Throat J; 1984 Jan; 63(1):48-51. PubMed ID: 6365514
    [No Abstract]   [Full Text] [Related]  

  • 19. Locally advanced esophageal carcinoma: at the crossroads of evidence-based medicine and patient care.
    Hwang JJ
    Clin Adv Hematol Oncol; 2003 May; 1(5):289-91; discussion 292. PubMed ID: 16224424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current perspective of treatment for advanced esophageal squamous cell carcinoma].
    Hamamoto Y; Kitagawa Y
    Nihon Shokakibyo Gakkai Zasshi; 2014 Feb; 111(2):253-9. PubMed ID: 24500314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.